Concepedia

Romy L.S. Mesman

RL

Statistics

Publications

7

Citations

292

H-Index

7

Active since

2014

Affiliations

Leiden University Medical Center(Current)

The University of Melbourne

University of Otago

Inserm

Fondazione IRCCS Istituto Nazionale dei Tumori

Romy L.S. Mesman is an author at Leiden University Medical Center specializing in genetics, life sciences, and cancer genetics.

ORCID

Publications per year

2014–2022

7

Publications

7

<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

Hermela Shimelis, Romy L.S. Mesman, Catharina Von Nicolai et al. · Cancer Research · 2017 · 93 citations · Full text

, , +17

The functional impact of variants of uncertain significance in BRCA2

Romy L.S. Mesman, Fabienne M.G.R. Calléja, Giel Hendriks et al. · Genetics in Medicine · 2018 · 87 citations · Full text

, , +15

Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2

Romy L.S. Mesman, Fabienne M.G.R. Calléja, Miguel de la Hoya et al. · Genetics in Medicine · 2020 · 40 citations · Full text

, , +17

Skipping Nonsense to Maintain Function: The Paradigm of <i>BRCA2</i> Exon 12

Laëtitia Meulemans, Romy L.S. Mesman, Sandrine M. Caputo et al. · Cancer Research · 2020 · 33 citations

, , +17

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

Hermela Shimelis, Romy L.S. Mesman, Catharina Von Nicolai et al. · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · 2017 · 15 citations · Full text

, , +16

1–5 of 7